Cardiovascular
After Cardiac Surgery
0
Pipeline Programs↗
10
Active Trials↗
1
Companies Involved↗
After Cardiac Surgery is an early-stage landscape with 0 programs across 1 company. The most active players are AM-Pharma.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
65
clinical trials
Completed33 · 51%
Unknown status14 · 22%
Recruiting5 · 8%
Not yet recruiting4 · 6%
Terminated4 · 6%
Withdrawn3 · 5%
Other2 · 3%
Clinical Trials
Trial Activity
65 trials
Natriuresis-guided Depletion After Cardiac Surgery
Recruiting·—·N/A·NCT07077772·102 enrolled
Intravenous Acetaminophen After Cardiac Surgery - Definitive Study
Recruiting·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·Phase 4·NCT06613178·1,100 enrolled
Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery
Not yet recruiting·TThe First Affiliated Hospital of Anhui Medical University·N/A·NCT07086287·120 enrolled
Intertransverse Process Block to Improve Quality of Recovery After Cardiac Surgery With Sternotomy
Not yet recruiting·—·N/A·NCT06926764·100 enrolled
1.Comparison of the Analgesic Effect of Remifentanil Group and Different Dose Groups of Oliceridine in Postoperative Patients Undergoing Cardiac Surgery 2.Exploring the Hemodynamic Effects of Analgesic Regimens With Different Doses of Oliceridine After Cardiac Surgery
Not yet recruiting·NNanjing First Hospital, Nanjing Medical University·Phase 4·NCT06619145·270 enrolled
Pain Management After Cardiac Surgery - Opioids or NSAID
Completed·—·Phase 4·NCT02479165·182 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)